opioid addiction

The U.S. Food and Drug Administration approved the first new pain reliever to hit the market in over 20 years. This medication, produced by Vertex Pharmaceuticals Inc (NASDAQ:VRTX), is a non-opioid and therefore non-addictive. The new drug, suzetrigine, will be sold under the brand name Journavx....

For many people struggling with opioid use disorder (OUD), accessing life-saving medications like methadone and buprenorphine (MOUD) has been hampered by a surprising hurdle: the requirement to abstain from cannabis. A new study published in the American Journal of Drug and Alcohol Abuse...

The beloved “Friends” star was reportedly found dead in a jacuzzi at his home in Los Angeles on Saturday afternoon. Matthew Perry was 54. Law enforcement sources told TMZ that first responders rushed to his home after receiving a call that a male was in cardiac distress....

This article was originally published on Microdose and appears here with permission Addiction is a complex and challenging condition that affects millions of individuals worldwide. Traditional treatment approaches often focus on managing withdrawal symptoms and addressing behavioral patterns....

Ron DeSantis signed a bill prohibiting sober living facilities from allowing residents to use or possess medical marijuana even if the individual has a recommendation from a physician. Florida legalized medical marijuana in 2016 when voters passed a constitutional amendment. DeSantis, who is...

King’s College London is the latest UK institution to sever all ties with the billionaire Sackler family amid outrage over its role in the deadly opioid epidemic in the U.S. that, as of 2021, has claimed the lives of more than 106,000 people.  The move comes several...

The Salem City Council unanimously passed a measure decriminalizing adult use of psilocybin mushrooms on Thursday, May 11.  Sponsored by Ward 7 Councilor Andy Varela and endorsed by Bay Staters for Natural Medicine, pharmacologist Miyabe Shields and Police Chief Lucas Miller...

The Food and Drug Administration has determined that certain naloxone products like Narcan are safe enough to potentially be sold without a prescription. Narcan, a brand name for naloxone, is a medication used to reverse the effects of opioids, usually in the case of an...

As of January 2023, Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances such as psilocybin, MDMA, LSD, mescaline, DMT and ketamine to those among its 4.5 million population suffering from mental health disorders. The decision...

The Canadian-based psychedelics company Nirvana Life Sciences Inc. filed a patent for the deuterated form of 7-hydroxymitragynine (D7-h.), commonly known as Kratom. Nirvana focuses on developing mental health therapeutics including non-addictive chronic pain and relapse-...

Primitiv, a Michigan-based cannabis company founded by former NFL stars Rob Sims and 2021 Pro Football Hall of Fame inductee, Calvin Johnson Jr., are opening the group’s flagship dispensary in Niles, Michigan.  In addition to the dispensary offering a...

The U.S. Food and Drug Administration (FDA) announced Wednesday that it is taking steps aimed to foster the development of non-addictive alternatives to opioids to manage acute pain and prevent new addiction. The agency issued draft guidance to provide recommendations to companies...

With drug overdoses having skyrocketed over the past two decades and deaths increased over four times in the period between 1999 and 2017, according to CDC data, it's no surprise that the number of those prone to opioid use disorder and opiate addiction is rising...

The FDA warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain. The agency said the opioid addiction treatment had been reported to cause tooth decay, infection, and, in some cases,...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has provided an update on its marketing application's status seeking approval for Zimhi's high-dose naloxone injection product to treat opioid overdose. Type A meeting with the FDA was concluded. The company believes the...